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Die Ergebnisse meiner Dissertation über die gegenseitige Beeinflussung von 
Pupillenweite und Perimetrie an der Universitäts-Augenklinik Tübingen wurden als 
Artikel bei der Zeitschrift „Vision Research“ unter dem Titel:  
 
Reciprocal effects of pupil size and perimetry 
A Pharmacological Model using Increment and Decrement Stimuli 
 
eingereicht. 
Auf den folgenden Seiten ist die englische Originalfassung, so wie sie eingereicht 
wurde, abgedruckt.  
Anschließend folgen eine deutsche Zusammenfassung und zusätzliche Diagramme, die 
in der eingereichten Fassung aus Platzgründen nicht Eingang finden konnten. 
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The influence of natural and pharmacologically induced pupil size fluctuations on 
differential luminance sensitivity threshold (DLS) was examined with increment and 
decrement stimuli in 12 healthy subjects using phenylephrine 2%, dapiprazole 0.5%, 
and placebo. Pupil size was recorded by infra-red video camera without and with visual 
field examination (Tübingen Computer Campimeter). We found campimetric 
examination itself had a stabilizing effect on pupil size fluctuations. Pupil size affected 
DLS on its own (slope 0.21 dB/mm; 95%-CI: 0.09 to 0.33 dB/mm), differently at 
different stimulus locations, and 0.13 dB/mm (95%-CI: 0.00 to 0.26 dB/mm) more with 
increment than with decrement stimuli. 
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Early perimetric studies suggest that the naturally occurring inter-individual differences 
in pupil diameter do not influence perimetry results (Aspinall, 1967;Williams, 
1983;Brenton & Phelps, 1986;Flammer et al, 1984). In contrast, pharmacologically 
(Day & Scheie, 1953;Engel, 1942;Harrington, 1981;McCluskey et al, 1986;Mikelberg 
et al, 1996;Forbes, 1966;Fitting & Mermoud, 1992;Rebolleda et al, 1992;Wood et al, 
1988;Lindenmuth et al, 1989;Lindenmuth et al, 1990) or physically (Gleissner & 
Lachenmayr, 1992) induced intra-individual differences in pupil diameter do seem to 
have an effect. This effect appears to be more marked in glaucoma patients (Day & 
Scheie, 1953;Engel, 1942;Harrington, 1981;Forbes, 1966;Fitting & Mermoud, 
1992;Rebolleda et al, 1992) than in normal subjects (McCluskey et al, 1986;Mikelberg 
et al, 1996;Wood et al, 1988;Lindenmuth et al, 1989;Lindenmuth et al, 1990), where 
some authors judged it to be clinically negligible (Mikelberg et al, 1996;Wood et al, 
1988). Both pharmacological contraction (Lindenmuth et al, 1989;Fitting & Mermoud, 
1992) and dilation (Lindenmuth et al, 1990;Rebolleda et al, 1992) of the pupil appear to 
cause an increase in mean defect. This suggests an optimal pupil size for perimetry. 
However, the applied medications may have affected other visual functions such as 
visual acuity or accommodation (Lindenmuth et al, 1989;Mordi et al, 1986;Wilcox et 
al, 1995). In none of the above studies was the pupil size measured throughout the 
perimetric session.  
Pupillographic studies have shown that pupil size and pupil size fluctuations are altered 
by a number of influences, including vigilance, fatigue, systemic medication and 
accommodation (Wilhelm et al, 1998;Lüdtke et al, 1998). It is thus probable, that the 





perimetric examination itself has an influence on the pupil. Yet pupil size changes 
during a perimetric session have not been addressed to date. In fact, the above studies 
only report pupil measurements taken at the beginning of the session, using simple 
rulers or gauges. 
The introduction of static dark (light decrement type) stimuli has shown promising 
results in the area of high-accuracy campimetry, such as revealing field losses missed by 
conventional luminance (light increment type) stimuli of equal size and duration 
(Mutlukan, 1993;Mutlukan, 1994). Dark stimuli, cause less scatter inducing diffuse 
retinal illumination, which is suspected to play a major role in the effect of pupil size on 
perimetric results obtained with bright stimuli (McCluskey et al, 1986;Gleissner & 
Lachenmayr, 1992;Lindenmuth et al, 1989). However, there is no literature pertaining 
to the effect of pupil size on perimetry using dark (decrement) stimuli. 
This study has three objectives: (I) To examine the naturally occurring fluctuations in 
pupil size within a campimatric (visual field) session, (II) to assess whether campimetric 
sessions affect the fluctuations in pupil size, and (III), to assess the effect of pupil size 
on the DLS of computer campimetry with bright (increment) as well as with dark 
(decrement) stimuli, using drugs to induce changes in the order of those naturally 
occurring during campimetric sessions. 
 





Participants and methods 
Twelve healthy volunteers, who had given informed written consent,  were recruited 
according to the following inclusion criteria: age 20-30 years; corrected near visual 
acuity (Birkhäuser reading test and OCULUS-Landolt-Ring test, 33 cm distance) ≥1.0 
(20/20); spherical ametropia between -2 and +2 diopters; cylindrical ametropia between 
-1 and +1 diopters; applanatory intraocular pressure below 20 mmHg; pupils isocoric, 
no relative afferent pupillary defect (RAPD) in the swinging flashlight test. No 
pathology in the anterior eye segments; especially no central opacities (slit lamp); 
neither central nor peripheral pathologies in the fundus (direct und indirect 
ophthalmoscopy, dilated pupils), normal stereoscopic vision (all figures recognized in 
the LANG-(II)-stereotest), no manifest strabism (cover-test), no motility disorders, no 
double-vision. Only the leading eye, established by the Rosenbach fixation test 
(Rosenbach, 1903), of each subject was examined. For the analysis of the results, the 
stimulus locations of the left-eyed subjects were mirrored along the vertical meridian to 
transform them into right-eyed positions. 
The Tübinger Computer Campimeter (TCC) consists of a calibrated high-resolution 
stimulus-presentation monitor (BARCO Kalibrator, German Distributor: BARCO, 
Kippenheim; 72 dpi; 1024×768 Pixel; 21 inch diagonal width; max. luminance 
L = 64 cd/m2) and a personal computer. To guarantee constant 10 cd/m2 background 
illumination throughout all sessions, weekly calibration measurements were done on 
32 points of the screen with a Minolta Luminance Meter LM 100 (Minolta, Osaka, 
Japan). In these calibration sessions, stimulus intensity was also controlled (Dietrich et 
al, 1996). For reasons of luminance stability, the monitor was always switched on at 





least 45 minutes before the first examination. The distance between monitor and cornea 
was 30 cm, so that the monitor represented a rectangular area of about 34° horizontal 
and 25° vertical “radius”. The subject sat in front of the high-resolution monitor and 
looked at the virtual center between four fixation dots in the center of the screen. These 
four dots, sized 24.0 arc minutes, were located at 1° eccentricity and had a luminance of 
17.75 cd/m2. The head of the subject was brought into position with the help of a 
combined chin-forehead support system with integrated infrared CCD camera 
(resolution 256 x 256 pixels) and infrared-LED panel for illumination of the eye. The 
examiner monitored the position of the subject’s eye and fixation behavior by a small 
video display showing the input of the infrared CCD camera. The optical system of the 
camera included a position cross with millimeter scaling. A frame-grabber card digitally 
registered the pupillographic recording every 40 ms (25 Hz) and analyzed it in real-
time, calculating pupil diameter and position (x/y).  
DLS was measured at 9 locations within the central 20° with the TCC (Figure1) using 
either bright or dark 26 min-of-arc stimuli (10 cd/m2 background luminance, 4-2-1-
dB-thresholding-strategy, 4 reversals). A stimulus lasted 200 ms and was always 
accompanied by an acoustic signal preceding it by 60 ms. The next stimulus 
presentation followed independently of the subject’s answer after a predefined interval 
of 1000 ms according to the ”yes/time-out” method (Lutz et al, 2001). A 10-second 
mock-test of the central DLS threshold was performed at the beginning of each 
session. 
DLS thresholds were estimated by the “maximum likelihood method”, based on a 
logistic regression model (“logit-analysis”). Clinical perimetry DLS thresholds are 





presented on a dB scale based on the difference ∆L between the respective stimulus 
intensity and the maximum intensity. To produce clinically comparable DLS values 
despite the comparatively low maximum intensity of the monitor, the DLS thresholds 















Each subject was examined four times (E1-4; see Table) on three separate days (Day 1-
3; each separated by at least three days to allow sufficient washout period of the eye 
drops). All examinations took place between 9 and 12 AM. All sessions began with a 5-
minute adaptation time to the 10 cd/m2 background illumination. In this time the exact 
procedure of the respective examination was again explained. Following adaptation, 
baseline pupillary size and fluctuations were recorded for five minutes in the first 
examination (E1) while the subjects sat in font of the campimeter, fixating the 10 cd/m2 
screen without perimetric testing. Then, one drop of the medication was placed in the 
subject’s leading eye. A different medication was applied on each examination day in 
blinded blockwise randomized order: the mydriatic phenylephrine 2% (Neosynephrin 
POS®; alpha-1 receptor agonist), the miotic dapiprazole 0.5% (Remydrial®; alpha-
receptor antagonist), or placebo (Isopto®-Naturale; isotonic saline solution). Two 
campimetric examinations (E2 and E3), one with bright and one with dark stimuli (in 
blockwise randomized order), were performed 25 and 35 minutes after drug application. 
The fourth examination (E4) took place 45 minutes after medication and was identical 





to E1. Refraction (NIDEK Auto Refractometer AR-600) and near visual acuity 
(OCULUS-Landolt-Ring test, 33 cm distance) were measured prior to as well as 20 and 




The statistical evaluation was performed in cooperation with the Institute of Medical 
Biometry of Tübingen University, using JMP 4.0.5 (SAS Institute Inc., SAS Campus 
Drive, Cary, NC, USA; http:// www.jmp.com/).  
The pupil diameter recordings were plotted against time and the artifacts (e.g. 
anatomically impossible pupil diameters) removed from the data set. The remaining 
artifacts were left in the graphical display of pupil diameter by time but removed for 
statistical analysis.  
The mean pupil diameter per examination (here called Pupil Size) and its standard 
deviation (here called Pupil Fluctuation) were secondary outcome measures. 
Determinants of Pupil Size were established in an analysis of variance (ANOVA) with 
factors medication, stimulus, and their interaction, and subject (random factor). The 
width of the 95%-confidence intervals (CI) for mean differences to placebo was 
adjusted as in Dunnett’s test (aCI). Only the examinations following medication 
application (E2 to E4) were included in this analysis. Baseline measurements were 
analyzed separately. The same procedure was used to explore the determinants of Pupil 
Fluctuation.  





For the analysis of the primary outcome measure DLS, Pupil Size was defined as the 
average pupil diameter - measured simultaneously to each stimulus presentation - per 
stimulus location and examination. An Analysis of Covariance (ANCOVA) was used to 
estimate the effects of stimulus type and location, Pupil Size, and their three two-way 
interactions, as well as day, and subject (random factor), on DLS. Inter- and intra-
individual effects of Pupil Size were separated by adjusting for subject, the known 
confounder, in a second run. Medication was assumed to have no direct effect on DLS 
besides that propagated by Pupil Size.  
Assumption of the linear model was checked by Box-Cox-transform, residual by 
predicted plot and quantile-quantile plot. 







Refraction and Visual Acuity 
After medication, near visual acuity decreased by one line in two of the 36 sessions (in 
both cases from 1.4 to 1.25; placebo sessions), and by two lines in one session (from 1.4 
to 1; phenylephrine session). Refraction changed by +0.25 diopters in 7 sessions 
(1 dapiprazole, 4 placebo, and 2 phenylephrine sessions) and by +0.5 diopters in one 
session (dapiprazole), by -0.25 diopters in 6 sessions (2 dapiprazole, 1 placebo, and 
3 phenylephrine sessions) and by -0.5 diopters in 1 session (dapiprazole). Thus the 
medication did neither have any systematic effect on visual acuity nor on refraction. 
 
Pupil Diameter 
The pupil diameter recordings were plotted against time and the artifacts (e.g. 
anatomically impossible pupil diameters, resulting mostly from blinking) removed from 
the data set (3% of all measurements). The remaining artifacts, (0.7% of all 
measurements: pupil diameter changing at >5 mm/s and graphically visualized outliers, 
usually also due to blinking) were left in the 144 graphs of pupil diameter by time but 
removed for statistical analysis.  
 
Baseline Pupil Size and Fluctuation 
The mean Pupil Size of all baseline (E1, prior to medication) examinations was 5.4 mm 
(SD 1.2 mm; range 2.4 mm - 8.7 mm). There was a marked inter-individual variation in 
baseline Pupil Size, which ranged from 3.4 mm to 7.7 mm. In contrast, intra-individual 





range in baseline Pupil Size was small (median 0.9 mm, range 0.2 mm – 1.8 mm). The 
SD of Pupil Fluctuation was 0.11 mm within and 0.12 mm between subjects. 
 
Pupil Size on medication 
The model for 108 examinations fitted the data well, achieving an adjusted coefficient 
of determination (aR2) of 0.83. Residual standard deviation was 0.60 mm, the grand 
mean Pupil Size was 5.7 mm. Dapiprazole 0.5% led to an average decrease in pupil 
diameter of 1.1 mm (aCI: -1.4 to -0.8 mm), and phenylephrine 2% to an average 
increase in pupil diameter of 0.4 mm (aCI: 0.1 mm to 0.7 mm), compared with placebo. 
The stimulus type (increment / decrement) did not affect pupil size (95%-CI: -0.4 to 
+0.5 mm). Intra-individual variance was 21%, and inter-individual variance 79% of 
random variance, respectively. 
 
Pupil Fluctuation on medication 
The model produced an aR2 of 0.64. Geometric mean of Pupil Fluctuation was 
0.27 mm. The residual coefficient of variation was 27%. Dapiprazole 0.5% led to an 
average decrease in Pupil Fluctuation by -22% (aCI: -33% to -10%), and phenylephrine 
2% to an average decrease in Pupil Fluctuation of -12 % (aCI: -23% to +1.6%), 
compared with placebo, where Pupil Fluctuation was 0.48mm (95%-CI: 0.19 mm to 
0.86 mm). Pupil Fluctuation was 35% higher (CI: 21% to 50%) when a subject is 
merely fixating the screen center as opposed to undergoing perimetric examination. 
Indeed, the 144 graphs of pupil diameter by time for each session showed that in most 





subjects the fluctuation in pupil diameter was greater in the purely pupillographic 
sessions without stimuli (E1 and E4) than in the perimetry sessions (E2 and E3). We 
first thought this phenomenon (Figure 2) was due to the medication, but found that on 
placebo days Pupil Fluctuation was increased by 63% (CI: 35% to 96%) when a subject 
is merely fixating the screen (Figures 3 and 4). Accordingly, the median range of pupil 
diameter within one examination was 2.0 mm (max. 4.0 mm) in the examinations 
without perimetry as opposed to 1.4 mm (max. 2.8 mm) in the examinations with 
perimetry. The suppressive effect of the perimetric examination on Pupil Fluctuation 
was slightly greater with dark stimuli than with bright stimuli (Figure 3).  
 
Differential luminance sensitivity (DLS) 
The model for 647 observations (aR2 0.73) led to an estimated residual standard 
deviation of 1.15 dB. (One of 648 DLS values  - day 1, E3, bright stimulus, dapiprazole, 
ID9 - was unfortunately missing because the respective subject only gave positive 
responses at that location.) The SD between the subjects was 0.83 dB (13 % of total 
variance). The main determinant of DLS was the stimulus location, explaining 55% of 
total variance. Mean DLS did not differ between stimulus type (CI: -0.20 to 0.16 dB for 
the difference of increment stimuli DLS to decrement stimuli DLS) overall, but 
decrement stimuli led to a 1.55 dB (CI: 1.02 to 2.09 dB) decrease in the visual field 
center (ID9). The training effect from day 1 to day 3 was minimal (0.2 dB; CI: -0.02 to 
0.42 dB). Pupil Size affected DLS on its own (slope 0.21 dB/mm; CI: 0.09 to 
0.33 dB/mm), differently at different stimulus locations, e.g. in the center (ID9), where 
slope was 0.39 dB/mm (CI: 0.18 to 0.60 dB/mm), and to a greater extent when 





increment stimuli were used (slope difference when using increment as opposed to 
decrement stimuli: 0.13 dB/mm; CI: 0.00 to 0.26 dB/mm). Figures 5a and 5b show the 
direct relationship between DLS-threshold and pupil diameter at each location, for 
increment and decrement stimuli, respectively. The effect of Pupil Size on DLS was 
largely due to intra-individual variations as were mainly caused by medication: after 
subtracting subjects’ mean Pupil Size and DLS, a similar model revealed practically the 
same effects; only interactions took different values. Particularly, DLS was 0.22 dB 
higher for every 1 mm of pupil size. 
 






Former studies on the effect of pupil size on perimetry used the fairly crude method 
(Schmitz et al, 2003) of a millimeter rule or the reticule of perimetric devices, and only 
assessed pupil size at the beginning of the session (Aspinall, 1967;Williams, 
1983;Brenton & Phelps, 1986;Flammer et al, 1984;Day & Scheie, 1953;Engel, 
1942;Harrington, 1981;McCluskey et al, 1986;Mikelberg et al, 1996;Forbes, 
1966;Fitting & Mermoud, 1992;Rebolleda et al, 1992;Wood et al, 1988;Lindenmuth et 
al, 1989;Lindenmuth et al, 1990;Gleissner & Lachenmayr, 1992). Our recordings of 
pupil size every 40 milliseconds allow not only “continuous” assessment of pupil size 
but thereby also of its fluctuations throughout sessions with and without perimetry. Our 
results show that the fluctuations in pupil size are reduced by more than 1/3 when a 
subject is undergoing a perimetric session as opposed to merely gazing at the screen 
center. This reduction in pupil size fluctuation is likely to reflect a more focused state 
and even level of concentration of the subjects during perimetry (Wilhelm et al, 
1998;Lüdtke et al, 1998). Thus, the pupil behaves differently during perimetry than 
before perimetry and should hence be measured during perimetric examination. 
Earlier pharmacological studies on the influence of pupil size on perimetry applied 
relatively strong medication (phenylephrine 10% (Wood et al, 1988;Rebolleda et al, 
1992;Pinkerton & Reifel, 1971), pilocarpine 2% (McCluskey et al, 1986;Lindenmuth et 
al, 1989;Rebolleda et al, 1992), tropicamide 1% (Lindenmuth et al, 1990), 
thymoxamine 0.5% (Wood et al, 1988;Mikelberg et al, 1996)), possibly affecting other 
visual functions such as visual acuity or accommodation via alteration of muscle tonus, 
blood flow, or retinal sensitivity (Lindenmuth et al, 1989;Mordi et al, 1986;Wilcox et 





al, 1995). In this study the medication dosage was kept low to minimize interference 
regarding accommodation or visual acuity and to keep pupillary size within the range 
encountered in normative studies (Wabbels et al, 1995). Both verum drugs 
(phenylephrine and dapiprazole) act on the smooth muscle of the pupil dilator. They 
also act on the ciliary body vasculature, but for young subjects the dosage used is 
unlikely to affect the constant accommodation required for fixation at the campimetric 
distance of 30 cm (Mordi et al, 1986;Wilcox et al, 1995). Indeed, we found no 
systematic effect of the medication on refraction or near visual acuity. Furthermore, the 
maximum intersession changes were completely within the physiological range (≤2 
lines for visual acuity and ≤ 0.5 diopters for refraction). Thus the medication neither had 
a systematic nor clinically relevant effect on refraction or visual acuity.  
 
We have assessed the naturally occurring degree of pupil size fluctuation during 
campimetric measurements and found that, in our study using low pharmacological 
doses, induced changes in mean pupil size and fluctuation were within the naturally 
occurring spectrum. Stronger doses of medication than the ones used in this study will 
lead to greater changes in pupil size, which in turn may have a more marked effect on 
visual thresholds, but also potentially on accommodation.  
 
A contractive effect of pupillary constriction on the visual field was already assumed in 
1862 (Haffmans, 1862). Yet empirical examinations suggested that the inter-individual 
differences in pupil size have only a negligible effect on the kinetic visual field 
thresholds (Aspinall, 1967;Williams, 1983). Examinations with static perimetry also led 
to the conclusion that in normal eyes pupil size does not have a significant influence on 





mean sensitivity (Aspinall, 1967;Brenton & Phelps, 1986). In normal subjects, pupil 
size did not affect short-time fluctuation (SF), whereas in glaucoma patients the latter 
was affected by miotic therapy (Flammer et al, 1984). Pharmacologically induced 
alterations in pupil size do seem to have a stronger effect on perimetric results. Drug-
induced miosis led to a contraction of manually assessed visual field isopters in healthy 
subjects as well as in glaucoma patients (Day & Scheie, 1953;Engel, 1942;Harrington, 
1981). Medically induced miosis has further been reported to cause visual field defects 
that mimic those found in glaucoma patients, and to worsen glaucomatous visual field 
defects (Day & Scheie, 1953;Forbes, 1966). McCluskey et al. have analyzed the effect 
of miosis caused by pilocarpine 2% in 16 healthy subjects aged 24 to 57 years using 
kinetic perimetry: they found that a pupil diameter below 2 mm correlated with a 
significant reduction of kinetic isopter area (McCluskey et al, 1986). Mikelberg et al. 
studied the effect of thymoxamine 0.5% on 22 eyes of volunteers aged 24 to 67 years 
using the Octopus Program G1. Mean pupil diameter decreased by 2.0 mm, 
(SD 0.7 mm) but this did not exert a significant effect on mean sensitivity, mean defect, 
correlated loss variance, or short-term fluctuation. However, they noted a high 
correlation between baseline pupil diameter and changes in pupil diameter, and further 
established a significant relationship between proportionate change in pupil diameter 
and proportionate change in mean sensitivity (Mikelberg et al, 1996). Wood et al. 
studied the effect of phenylephrine 10% and thymoxamine 0.5% on mean sensitivity 
and short-term fluctuation (Dicon AP3000 perimeter) of 10 healthy young adults and 
expressed the results in terms of eccentricity. The effect of pupil size was greater at 
peripheral angles outside 10° and was reported to reach a maximum value of 7 dB for a 
pupil size difference of 3.7 mm. However, the authors concluded that within the normal 





range of pupil sizes the effect of pupil size is clinically negligible (Wood et al, 1988). 
Lindenmuth et al. studied 20 healthy subjects on the Humphrey Field Analyzer before 
and after the application of one drop of pilocarpine 2%. Mean pupil area decreased from 
16.3 mm2 (SD 6.1 mm2) to 4.3 mm2 (SD 1.9 mm2) and was accompanied by a 
worsening of the mean defect by 0.7 dB (SD 0.7 dB). Here, too, the effect of pupil 
constriction on differential luminance sensitivity was stronger in the periphery. They 
explained this effect in terms of reduced retinal illumination and diffraction 
(Lindenmuth et al, 1989). Gleissner und Lachenmayr ruled out pharmacological 
side-effects in their experiment by placing pinholes of 1, 2, 3 and 4 mm diameters, 
respectively, in front of the eyes of normal subjects. In both, perimetry (Humphrey 
Field Analyzer) and flicker perimetry, pinhole size reduction led to a logarithmic 
reduction in DLS threshold values, whereby the effect was particularly marked when 
the artificial pupil was smaller than 2 mm in diameter. This effect was interpreted as 
being purely a function of retinal illumination (Gleissner & Lachenmayr, 1992). After 
pausing miotic medication, the pupil diameter of 8 glaucoma patients studied by Fitting 
and Mermoud increased by 2.0 mm (SD 0.8 mm), together with a reduction of the mean 
defect by 1.9 dB (SD 1.5 dB) (Fitting & Mermoud, 1992).  
The effect of pharmacologically induced pupil dilation has also been examined. An 
increase in mean pupil area from 17.8 mm2 (SD 4.3 mm2) to 47.1 mm2 (SD 7.0 mm2) 
using tropicamide 1% is reported to have increased the mean defect by 0.8 dB (SD 
0.9 dB) in 18 healthy subjects (Lindenmuth et al, 1990). Similar results were also 
obtained in glaucoma patients: in 18 patients with open-angle-Glaucoma on 
pilocarpine 2% treatment, one drop of phenylephrine 10% led to an increase in pupil 
area from 2.9 mm2 (SD 1.8 mm2) to 26.1 mm2 (SD 14.0 mm2), which was paralleled by 





an average increase in mean defect of 3.1 (SD 2.6 dB). However, no significant effect 
on the foveola threshold was found; the effect increased markedly with increasing 
eccentricity (Rebolleda et al, 1992).  
 
Our study shows that for the central 20° in normal young subjects the effect of pupil 
diameter in the order of magnitude of natural size fluctuatuations on DLS thesholds is 
not relevant intra-individually, as the intra-individual median range of 0.9 mm causes 
only a 0.2 dB DLS change. We thus agree with the authors who judged the effect of 
pupil size on DLS to be negligible in serial examinations in young healthy subjects 
(Mikelberg et al, 1996;Wood et al, 1988). The pupil is probably not the cause for the 
inter-test variation of up to 4 dB (Wilensky & Joondeph, 1984) found in such subjects. 
The effect of pupil size on DLS using bright stimuli found in our study is in the lower 
range of those found in former pharmacological studies in healthy subjects (0.2 dB to 
3.1 dB (Mikelberg et al, 1996;Lindenmuth et al, 1989;Lindenmuth et al, 1990), with a 
maximum of 7.0 dB (Wood et al, 1988)). This may in part be due to the stronger 
medication in these studies affecting also accommodation (Lindenmuth et al, 
1989;Mordi et al, 1986;Wilcox et al, 1995). The stronger medication in former studies 
may also account for the apparently contradictory results between these studies and the 
ones in which pupil size was not pharmacologically modulated (Aspinall, 1967;Brenton 
& Phelps, 1986;Flammer et al, 1984). It may also explain why both, miotic medication 
(Day & Scheie, 1953;Engel, 1942;Harrington, 1981;Forbes, 1966;McCluskey et al, 
1986;Mikelberg et al, 1996;Wood et al, 1988;Lindenmuth et al, 1989) and mydriatic 
medication (Lindenmuth et al, 1990;Rebolleda et al, 1992), led to a deterioration of 
visual field indices (Engel, 1942;Day & Scheie, 1953;Forbes, 1966;Harrington, 





1981;McCluskey et al, 1986;Mikelberg et al, 1996;Wood et al, 1988;Lindenmuth et al, 
1989;Lindenmuth et al, 1990;Rebolleda et al, 1992), whereas pausing miotic 
medication in glaucoma patients led to a reduction of the mean defect by 1.9 dB (Fitting 
& Mermoud, 1992). An alternative – or additional – explanation is that every individual 
has their own optimal pupil size for a particular perimetric situation, so that any 
artificial miosis or mydriasis would lead to suboptimal sensitivity.  
 
A strength of our models were residual standard deviations that were very close to the 
measurement error of repeated measurements under constant conditions, thus they seem 
to have caught all existing systematic effects. On the other hand, twelve subjects may 
not be representative. We also failed to show an increasing effect of pupil size on DLS 
with increasing eccentricity, as has been reported to various degrees in some earlier 
studies (Wood et al, 1988;Lindenmuth et al, 1989;Rebolleda et al, 1992). This may be 
due to the fact that we only examined the central 20° of the visual field. We found no 
relevant training effect from day 1 to day 3. This may in part be doe to the fact that we 
“primed” our subjects with a 10-second mock-test of the central DLS threshold at the 
beginning of each session. The effect of training in perimetry is a controversial matter: 
some authors report a 1.3 to 1.4 dB improvement of mean sensitivity (Searle et al, 
1991;Heijl et al, 1989) while others found no systematic change with experience 
(Aulhorn & Harms, 1972;Gloor et al, 1981;Lutz et al, 2001). 
 
Inter-individual differences in mean pupil size per examination were substantial, 
ranging from 3.4 mm to 7.7 mm in our study, and may theoretically be responsible for 
inter-individual differences in DLS, but our results indicate that this is not the case, as 





was inferred indirectly by considering the difference between the unadjusted and 
adjusted estimates of slope. Thus inter-individual differences in pupil diameter should 
not play a clinically relevant role in inter-individual DLS differences. 
 
The stronger effect of pupil size on DLS thresholds with bright stimuli than with dark 
stimuli is in agreement with the theory that decrement stimuli cause less diffraction and 
diffuse retinal illumination (Mutlukan, 1994), which are suspected to play a major role 
in the effect of pupil size on perimetric results obtained with bright stimuli (Lindenmuth 
et al, 1989;Gleissner & Lachenmayr, 1992). It is unclear whether the Off-system, which 
may be the main target of decrement stimuli (Wabbels et al, 1995), plays a role in this 
stimulus-related difference of the effect of pupil size on DLS.  
 
Conclusion 
Pupil size and pupil size fluctuations vary considerably between young subjects. We 
show for the first time that campimetric examinations have a stabilizing effect on pupil 
size fluctuations. Pupil size affects DLS with bright stimuli more than with dark stimuli. 
In normal young subjects the effect of pupil size in the range of natural size fluctuation 
on DLS is not relevant for clinical or normative studies.
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Figures and Table 








Figure 1: Examination grid with the nine tested locations 
Table : Examination procedure 
Figure 2: The stabilizing effect of perimetric examination on Pupil Fluctuation: Pupil 
Fluctuation was reduced in the sessions with perimetry (E2 and E3) as 
compared to the merely pupillographic sessions without perimetry (E1 and 
E4). The horizontal line represents the geometric mean of all 144 
examinations. The dots represent average pupil size fluctuation per subject 
and per session. The diamonds portray the mean (middle horizontal line), 
95%-CI (vertical diamond span), and 90%-CI (height between small 
horizontal lines) per examination type. 
Figure 3: Pupil Fluctuation by medication: the mean of each session has a different sign 
depending on the stimulus (° without perimetry , c bright, z dark,). A 
horizontal bar marks the stimulus-specific grand mean for each medication 
type. Fluctuations were highest without perimetry and lowest with dark stimuli. 
Figure 4: Matched pairs Bland/Altman plot of the difference between pupil size 
fluctuations during recordings while a subject is undergoing perimetry (With 
Peri) and merely gazing at the screen center (Without Peri), plotted against the 
mean Pupil Fluctuation for both situations, using the measurement data from 
placebo days only (see also figure 2). 





}*: 95% confidence interval; }†: reference interval, the twelve pairs of signs 
represent the twelve subjects.  
 
 
Figure 5: Differential luminance sensitivity (DLS) threshold plotted by mean pupil 
diameter for each stimulus location (ID 1-9; the graphics are arranged 
according to the stimulus localization – see Figure 1),  for bright stimuli (a) 
and for dark stimuli (b). Each subject is marked by a different symbol (the 
same as in Figure 3) and was measured three times (phenylephrine, placebo, 
dapiprazole) at each location.  


































































































































*: 95% confidence interval;  †: reference interval 
The twelve pairs of signs represent the twelve subjects,  
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-15 min Refraction and visual acuity tests 
-10 min Adaptation to background illumination (5min) 
-5 min E1:  Pupillography (5min) 
0 min Drops application (miotic/placebo/mydriatic) 
20 min Refraction and visual acuity tests 
25 min E2:  Pupillography + perimetry (in- or decrement; 5 min) 
32 min E3:  Pupillography + perimetry (de- or increment ;5 min) 
45 min E4:  Pupillography (5min) 
50 min Refraction and visual acuity tests 
 







Ziel dieser Studie war es, natürlich vorkommenden Pupillenschwankungen während 
perimetrischen Untersuchungen zu erfassen, und die Wechselwirkungen zwischen 
Pupillenweite und der Lokalen Lichtunterschiedsempfindlichkeit (LUE) für helle 
(inkrement) und dunkle (dekrement) Stimuli zu evaluieren. 
 
Probanden und Methoden: 12 gesunde Probanden (Alter 20-30 Jahre) wurden an drei 
verschiedenen Tagen unter dem Einfluss von jeweils Phenylephrin 2%, Dapiprazol 
0.5% und Placebo untersucht. Die Pupillenweite wurde mit einer Infrarot-Videokamera 
vor Medikamentenapplikation, während der 25 Minuten nach Medikamentenapplikation 
beginnenden campimetrischen Untersuchungen am Tübingen Computer Campimeter 
(TCC) und 45 Minuten nach Medikation digital registriert. Die lokale LUE wurde an 9 
Testorten innerhalb der zentralen 20° mit Hilfe des TCC in zwei getrennten Sitzungen 
mittels heller (inkrement) und dunkler (dekrement) Stimuli ermittelt (10 cd/m2 
Hintergrundleuchtdichte, 4-2-1-dB-Schwellenstrategie, 4 Schwellenüberschreitungen, 
Stimulus-„Durchmesser“ 26-Bogenminuten).  
 
Ergebnisse: Es zeigten sich erhebliche interindividuelle Unterschiede in der 
Pupillenweite und deren Standardabweichungen. Hingegen waren die intraindividuellen 
Unterschiede gering. Im Durchschnitt betrug der Einfluss der Pupillenweite auf die 
LUE 0.21 dB/mm (95%-Confidenzintervall: 0.09 bis 0.33 dB/mm). Dieser Einfluss war 
abhängig von der Stimuluslokalisation, und geringer, wenn dunkle Stimuli verwendet 
wurden (Steigungsunterschied zwischen dunklen und hellen Stimuli: 0.13 dB/mm; 
95%-CI: 0.00 bis 0.26 dB/mm). Trotz der erheblichen interindividuellen Unterschiede 
in der Pupillenweite war der Einfluss der Pupillenweite auf die LUE fast ausschließlich 
auf intraindividuelle Unterschiede zurückzuführen. 
 





Schlussfolgerung: Perimetrische Untersuchungen haben einen stabilisierenden Einfluss 
auf Pupillenschwankungen. Die Pupillenweite beeinflusst die Ergebnisse der Inkrement 
Perimetrie mehr als die der Dekrement Perimetrie. Bei gesunden jungen Probanden ist 
dieser Effekt in der Größenordnung natürlich schwankender Fluktuationen der 
Pupillenweite nicht relevant für klinische Studien oder Normwert- Studien. 
 
 























Anhang: Nicht zur Publikation eingereichte Abbildungen 




















Figure A1. Photographs of the examination unit 
 
a) Tübinger Computer Campimeter with infra-red video camera 
 
b) Pupil monitoring unit  



















recording of pupil 
diameter and 
position 
Real-time movie of 
the subject’s eye 





Table A1. Improvement or worsening of refraction after medication. No systematic 





























Dapiprazole  -0.5 1 
Dapiprazole  -0.25 2 
Dapiprazole  0 2 
Dapiprazole  0.25 1 
Dapiprazole  0.5 1 
Placebo  -0.5 1 
Placebo  -0.25 1 
Placebo  0 2 
Placebo  0.25 4 
Phenylephrine  -0.25 3 
Phenylephrine  0 2 
Phenylephrine  0.25 2 




















Figure A2: Example of how pupil size fluctuations are reduced in the campimetric 
examinations (E2 and E3) as compared to the merely pupillographic sessions without 
perimetry (E1 and E4), on a placebo-day. Pupil diameter is plotted by time. The straight 
lines portray a linear fit.  
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Figure A3. The stabilizing effect of perimetric examination on pupil fluctuations: the 
fluctuations in Pupil size (SD ø [mm]) were reduced in the sessions with perimetry 
(E2 and E3) as compared to the merely pupillographic sessions without perimetry (E1 
and E4). The dots represent average pupil size fluctuation per subject and per session. 
The diamonds portray the mean (diamond middle line) and 95% confidence interval 
(vertical diamond height) per examination type. 




















































Table A2. Summary of the DLS and pupil diameter values per subject (Subj), day, 
examination (E), medication (Med: 1 dapiprazole, 2 placebo, 3 phenylephrine), stimulus 
type (Stim: 1 increment, 2 decrement) and (ID). Typ: the subject’s answers to stimulus 
presentation either overlapped the respective DLS threshold (Ÿberschn.; in 183 cases) 
or there was a clear-cut threshold (getrennt; in 464 cases); in one case, DLS threshold 
could not be estimated as the subject answered positively to all stimulus intensities 
(nur Ja). The subject-centered values of pupil diameter and LUE are also shown. 
 
 













1 1 2 1 1 1 getrennt 28.00 3.67 0.17 -1.12 -2.06 
1 1 2 1 1 2 getrennt 28.90 3.62 0.28 -1.17 -1.16 
1 1 2 1 1 3 getrennt 29.50 3.68 0.29 -1.12 -0.56 
1 1 2 1 1 4 getrennt 27.40 3.69 0.20 -1.11 -2.66 
1 1 2 1 1 5 getrennt 26.35 3.74 0.24 -1.06 -3.71 
1 1 2 1 1 6 getrennt 30.90 3.17 1.22 -1.62 0.84 
1 1 2 1 1 7 Ÿberschn. 29.20 3.76 0.21 -1.03 -0.86 
1 1 2 1 1 8 getrennt 27.95 3.60 0.19 -1.19 -2.11 
1 1 2 1 1 9 Ÿberschn. 32.99 3.67 0.30 -1.12 2.94 
1 1 3 1 2 1 getrennt 28.70 3.85 0.34 -0.95 -1.36 
1 1 3 1 2 2 Ÿberschn. 27.87 3.60 0.31 -1.20 -2.18 
1 1 3 1 2 3 Ÿberschn. 29.58 4.09 0.13 -0.71 -0.48 
1 1 3 1 2 4 getrennt 28.10 3.61 0.31 -1.18 -1.96 
1 1 3 1 2 5 getrennt 28.10 3.79 0.22 -1.00 -1.96 
1 1 3 1 2 6 Ÿberschn. 29.73 4.07 0.22 -0.73 -0.33 
1 1 3 1 2 7 Ÿberschn. 30.32 3.86 0.38 -0.94 0.27 
1 1 3 1 2 8 getrennt 27.60 3.60 0.27 -1.20 -2.46 
1 1 3 1 2 9 Ÿberschn. 31.86 3.95 0.29 -0.84 1.81 
1 2 2 2 1 1 getrennt 29.30 5.78 0.17 0.98 -0.76 
1 2 2 2 1 2 getrennt 30.10 5.72 0.13 0.92 0.04 
1 2 2 2 1 3 getrennt 29.90 5.72 0.17 0.93 -0.16 
1 2 2 2 1 4 Ÿberschn. 30.69 5.67 0.23 0.87 0.63 
1 2 2 2 1 5 Ÿberschn. 28.58 5.79 0.11 0.99 -1.47 
1 2 2 2 1 6 getrennt 29.90 5.65 0.20 0.85 -0.16 
1 2 2 2 1 7 getrennt 31.60 5.63 0.28 0.83 1.54 
1 2 2 2 1 8 getrennt 29.60 5.75 0.18 0.96 -0.46 
1 2 2 2 1 9 getrennt 35.45 5.67 0.18 0.88 5.39 
1 2 3 2 2 1 getrennt 28.70 5.18 0.35 0.38 -1.36 
1 2 3 2 2 2 Ÿberschn. 31.06 5.05 0.31 0.25 1.00 
1 2 3 2 2 3 getrennt 29.70 4.77 0.30 -0.03 -0.36 
1 2 3 2 2 4 getrennt 28.70 5.15 0.27 0.36 -1.36 
1 2 3 2 2 5 getrennt 29.30 5.03 0.32 0.23 -0.76 
1 2 3 2 2 6 getrennt 31.00 5.23 0.29 0.44 0.94 
1 2 3 2 2 7 Ÿberschn. 29.58 5.00 0.47 0.21 -0.48 
1 2 3 2 2 8 Ÿberschn. 30.55 5.29 0.30 0.49 0.50 
1 2 3 2 2 9 getrennt 32.20 5.13 0.36 0.34 2.14 





Table A2 continued 













1 3 2 3 1 1 Ÿberschn. 29.59 5.15 0.20 0.36 -0.47 
1 3 2 3 1 2 getrennt 30.10 5.28 0.26 0.48 0.04 
1 3 2 3 1 3 Ÿberschn. 30.55 5.37 0.17 0.58 0.50 
1 3 2 3 1 4 getrennt 30.00 5.14 0.16 0.34 -0.06 
1 3 2 3 1 5 getrennt 28.10 5.10 0.20 0.31 -1.96 
1 3 2 3 1 6 getrennt 30.40 5.13 0.20 0.34 0.34 
1 3 2 3 1 7 getrennt 31.60 5.18 0.29 0.38 1.54 
1 3 2 3 1 8 getrennt 30.00 5.17 0.23 0.38 -0.06 
1 3 2 3 1 9 Ÿberschn. 36.45 5.29 0.29 0.49 6.39 
1 3 3 3 2 1 getrennt 29.70 5.39 0.09 0.60 -0.36 
1 3 3 3 2 2 Ÿberschn. 31.95 5.26 0.20 0.47 1.89 
1 3 3 3 2 3 getrennt 30.10 5.25 0.18 0.45 0.04 
1 3 3 3 2 4 getrennt 28.10 5.35 0.16 0.56 -1.96 
1 3 3 3 2 5 getrennt 30.10 5.25 0.14 0.45 0.04 
1 3 3 3 2 6 getrennt 30.00 5.44 0.21 0.65 -0.06 
1 3 3 3 2 7 getrennt 30.10 5.32 0.19 0.52 0.04 
1 3 3 3 2 8 getrennt 30.55 5.28 0.13 0.49 0.49 
1 3 3 3 2 9 Ÿberschn. 36.65 5.37 0.27 0.58 6.59 
2 1 2 3 2 1 getrennt 29.70 5.32 0.28 -0.17 -0.63 
2 1 2 3 2 2 Ÿberschn. 32.92 5.38 0.20 -0.11 2.60 
2 1 2 3 2 3 Ÿberschn. 31.92 5.45 0.32 -0.04 1.60 
2 1 2 3 2 4 getrennt 28.70 5.37 0.59 -0.12 -1.63 
2 1 2 3 2 5 getrennt 28.70 5.38 0.27 -0.11 -1.63 
2 1 2 3 2 6 getrennt 30.50 5.48 0.20 -0.01 0.17 
2 1 2 3 2 7 Ÿberschn. 30.72 5.48 0.30 -0.01 0.40 
2 1 2 3 2 8 getrennt 32.20 5.40 0.16 -0.09 1.87 
2 1 2 3 2 9 getrennt 34.00 5.33 0.20 -0.16 3.67 
2 1 3 3 1 1 getrennt 31.70 5.70 0.40 0.21 1.37 
2 1 3 3 1 2 getrennt 31.00 5.78 0.24 0.29 0.67 
2 1 3 3 1 3 getrennt 33.90 5.94 0.22 0.45 3.57 
2 1 3 3 1 4 getrennt 30.00 5.85 0.34 0.36 -0.33 
2 1 3 3 1 5 getrennt 28.75 5.57 0.24 0.08 -1.58 
2 1 3 3 1 6 getrennt 30.90 5.71 0.20 0.22 0.57 
2 1 3 3 1 7 Ÿberschn. 29.42 5.82 0.37 0.33 -0.90 
2 1 3 3 1 8 getrennt 31.60 5.53 0.29 0.04 1.27 
2 1 3 3 1 9 getrennt 37.00 5.87 0.51 0.38 6.67 
2 2 2 2 2 1 Ÿberschn. 29.60 7.01 0.28 1.52 -0.72 
2 2 2 2 2 2 Ÿberschn. 30.36 6.92 0.31 1.43 0.04 
2 2 2 2 2 3 getrennt 29.70 6.75 0.21 1.26 -0.63 
2 2 2 2 2 4 getrennt 28.10 7.09 0.26 1.60 -2.23 
2 2 2 2 2 5 Ÿberschn. 25.14 6.79 0.33 1.30 -5.18 
2 2 2 2 2 6 Ÿberschn. 30.71 6.89 0.27 1.40 0.39 
2 2 2 2 2 7 getrennt 28.10 7.10 0.15 1.62 -2.23 
2 2 2 2 2 8 getrennt 29.20 6.95 0.31 1.46 -1.13 





Table A2 continued 













2 2 2 2 2 9 getrennt 34.00 6.92 0.49 1.43 3.67 
2 2 3 2 1 1 getrennt 28.55 6.19 0.30 0.71 -1.78 
2 2 3 2 1 2 getrennt 29.90 6.87 0.27 1.38 -0.43 
2 2 3 2 1 3 getrennt 30.55 6.90 0.17 1.41 0.22 
2 2 3 2 1 4 getrennt 28.00 6.61 0.26 1.12 -2.33 
2 2 3 2 1 5 getrennt 28.55 6.78 0.19 1.29 -1.78 
2 2 3 2 1 6 Ÿberschn. 30.26 6.60 0.29 1.11 -0.07 
2 2 3 2 1 7 getrennt 26.80 6.70 0.29 1.21 -3.53 
2 2 3 2 1 8 getrennt 29.90 6.59 0.37 1.10 -0.43 
2 2 3 2 1 9 getrennt 35.45 6.87 0.12 1.38 5.12 
2 3 2 1 2 1 getrennt 28.70 3.91 0.79 -1.58 -1.63 
2 3 2 1 2 2 getrennt 30.10 3.61 1.63 -1.88 -0.23 
2 3 2 1 2 3 Ÿberschn. 30.62 4.14 0.85 -1.35 0.29 
2 3 2 1 2 4 getrennt 28.70 4.04 0.85 -1.45 -1.63 
2 3 2 1 2 5 getrennt 29.30 4.56 0.42 -0.93 -1.03 
2 3 2 1 2 6 getrennt 31.60 4.26 1.06 -1.23 1.27 
2 3 2 1 2 7 getrennt 28.70 4.03 1.31 -1.46 -1.63 
2 3 2 1 2 8 getrennt 30.00 4.41 0.41 -1.08 -0.33 
2 3 2 1 2 9 getrennt 35.50 4.45 0.69 -1.04 5.17 
2 3 3 1 1 1 getrennt 28.55 4.10 0.25 -1.39 -1.78 
2 3 3 1 1 2 getrennt 29.90 3.88 0.04 -1.61 -0.43 
2 3 3 1 1 3 getrennt 28.60 3.87 0.11 -1.62 -1.73 
2 3 3 1 1 4 getrennt 28.00 3.98 0.29 -1.51 -2.33 
2 3 3 1 1 5 getrennt 27.40 4.04 0.37 -1.45 -2.93 
2 3 3 1 1 6 getrennt 30.50 4.12 0.27 -1.37 0.17 
2 3 3 1 1 7 Ÿberschn. 27.45 4.09 0.18 -1.40 -2.87 
2 3 3 1 1 8 Ÿberschn. 30.41 4.05 0.15 -1.44 0.09 
2 3 3 1 1 9 getrennt 37.00 4.00 0.20 -1.49 6.67 
3 1 2 3 1 1 getrennt 32.30 9.06 0.17 1.17 1.63 
3 1 2 3 1 2 getrennt 32.30 9.01 0.27 1.12 1.63 
3 1 2 3 1 3 getrennt 30.40 9.08 0.17 1.19 -0.27 
3 1 2 3 1 4 getrennt 28.55 8.94 0.38 1.05 -2.12 
3 1 2 3 1 5 Ÿberschn. 28.74 9.07 0.18 1.18 -1.92 
3 1 2 3 1 6 getrennt 30.90 9.04 0.19 1.15 0.23 
3 1 2 3 1 7 getrennt 27.40 8.22 1.35 0.34 -3.27 
3 1 2 3 1 8 getrennt 29.60 9.03 0.20 1.14 -1.07 
3 1 2 3 1 9 Ÿberschn. 35.04 9.00 0.17 1.11 4.38 
3 1 3 3 2 1 getrennt 29.70 8.64 0.74 0.76 -0.97 
3 1 3 3 2 2 getrennt 30.10 8.99 0.13 1.10 -0.57 
3 1 3 3 2 3 getrennt 30.10 8.92 0.21 1.04 -0.57 
3 1 3 3 2 4 getrennt 27.20 8.86 0.32 0.97 -3.47 
3 1 3 3 2 5 getrennt 28.10 8.80 0.36 0.91 -2.57 
3 1 3 3 2 6 getrennt 30.00 8.68 0.34 0.79 -0.67 
3 1 3 3 2 7 getrennt 28.70 8.89 0.20 1.01 -1.97 
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3 1 3 3 2 8 getrennt 30.55 8.97 0.14 1.08 -0.12 
3 1 3 3 2 9 getrennt 32.20 8.76 0.14 0.87 1.53 
3 2 2 1 1 1 getrennt 31.10 6.16 0.14 -1.72 0.43 
3 2 2 1 1 2 getrennt 32.30 6.19 0.16 -1.70 1.63 
3 2 2 1 1 3 Ÿberschn. 33.09 6.21 0.17 -1.68 2.43 
3 2 2 1 1 4 getrennt 29.60 6.17 0.09 -1.71 -1.07 
3 2 2 1 1 5 getrennt 27.80 6.25 0.19 -1.63 -2.87 
3 2 2 1 1 6 getrennt 31.50 6.11 0.13 -1.78 0.83 
3 2 2 1 1 7 getrennt 30.00 6.23 0.19 -1.65 -0.67 
3 2 2 1 1 8 getrennt 31.00 6.21 0.17 -1.68 0.33 
3 2 2 1 1 9 getrennt 33.90 6.12 0.24 -1.77 3.23 
3 2 3 1 2 1 getrennt 29.30 6.19 0.42 -1.70 -1.37 
3 2 3 1 2 2 Ÿberschn. 30.76 6.23 0.20 -1.66 0.09 
3 2 3 1 2 3 getrennt 30.10 6.12 0.40 -1.77 -0.57 
3 2 3 1 2 4 getrennt 30.60 6.29 0.18 -1.60 -0.07 
3 2 3 1 2 5 Ÿberschn. 30.56 6.29 0.22 -1.59 -0.10 
3 2 3 1 2 6 getrennt 29.20 6.21 0.46 -1.68 -1.47 
3 2 3 1 2 7 getrennt 28.10 5.63 1.70 -2.26 -2.57 
3 2 3 1 2 8 getrennt 30.10 6.19 0.26 -1.69 -0.57 
3 2 3 1 2 9 getrennt 35.50 6.04 0.27 -1.85 4.83 
3 3 2 2 1 1 getrennt 30.10 8.65 0.25 0.76 -0.57 
3 3 2 2 1 2 getrennt 31.00 8.63 0.17 0.74 0.33 
3 3 2 2 1 3 getrennt 30.90 8.45 0.33 0.56 0.23 
3 3 2 2 1 4 getrennt 31.60 8.67 0.22 0.78 0.93 
3 3 2 2 1 5 Ÿberschn. 30.55 8.77 0.13 0.88 -0.11 
3 3 2 2 1 6 Ÿberschn. 33.05 8.64 0.19 0.75 2.38 
3 3 2 2 1 7 getrennt 30.00 8.58 0.20 0.70 -0.67 
3 3 2 2 1 8 Ÿberschn. 33.15 8.69 0.22 0.80 2.48 
3 3 2 2 1 9 getrennt 35.45 8.66 0.22 0.78 4.78 
3 3 3 2 2 1 Ÿberschn. 30.36 8.61 0.21 0.73 -0.31 
3 3 3 2 2 2 getrennt 30.60 8.54 0.14 0.65 -0.07 
3 3 3 2 2 3 getrennt 29.70 8.53 0.21 0.64 -0.97 
3 3 3 2 2 4 Ÿberschn. 29.32 8.69 0.23 0.80 -1.34 
3 3 3 2 2 5 getrennt 30.10 8.61 0.12 0.72 -0.57 
3 3 3 2 2 6 getrennt 30.00 8.63 0.20 0.74 -0.67 
3 3 3 2 2 7 getrennt 28.70 8.67 0.15 0.78 -1.97 
3 3 3 2 2 8 getrennt 30.10 8.46 0.13 0.57 -0.57 
3 3 3 2 2 9 Ÿberschn. 34.85 8.65 0.22 0.76 4.19 
4 1 2 3 1 1 Ÿberschn. 27.65 7.72 0.17 1.18 -2.01 
4 1 2 3 1 2 Ÿberschn. 30.31 7.61 0.20 1.07 0.64 
4 1 2 3 1 3 Ÿberschn. 30.55 7.63 0.15 1.09 0.89 
4 1 2 3 1 4 getrennt 25.70 7.72 0.14 1.19 -3.97 
4 1 2 3 1 5 Ÿberschn. 27.45 7.69 0.14 1.16 -2.21 
4 1 2 3 1 6 getrennt 30.40 7.80 0.11 1.26 0.73 
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4 1 2 3 1 7 getrennt 30.50 7.81 0.13 1.27 0.83 
4 1 2 3 1 8 getrennt 31.60 7.77 0.10 1.23 1.93 
4 1 2 3 1 9 Ÿberschn. 35.63 7.63 0.20 1.10 5.96 
4 1 3 3 2 1 Ÿberschn. 26.75 7.74 0.12 1.21 -2.91 
4 1 3 3 2 2 getrennt 30.10 7.67 0.13 1.13 0.43 
4 1 3 3 2 3 Ÿberschn. 29.54 7.67 0.18 1.13 -0.12 
4 1 3 3 2 4 getrennt 27.65 7.74 0.11 1.21 -2.02 
4 1 3 3 2 5 getrennt 28.70 7.77 0.13 1.23 -0.97 
4 1 3 3 2 6 getrennt 30.00 7.62 0.13 1.09 0.33 
4 1 3 3 2 7 Ÿberschn. 29.48 7.67 0.14 1.13 -0.19 
4 1 3 3 2 8 getrennt 30.10 7.61 0.10 1.07 0.43 
4 1 3 3 2 9 getrennt 32.20 7.72 0.14 1.18 2.53 
4 2 2 2 1 1 getrennt 28.00 6.24 0.52 -0.30 -1.67 
4 2 2 2 1 2 Ÿberschn. 30.72 6.42 0.15 -0.11 1.06 
4 2 2 2 1 3 getrennt 30.40 6.28 0.23 -0.25 0.73 
4 2 2 2 1 4 getrennt 26.50 6.64 0.20 0.10 -3.17 
4 2 2 2 1 5 getrennt 27.30 6.48 0.10 -0.05 -2.37 
4 2 2 2 1 6 Ÿberschn. 30.82 6.47 0.11 -0.07 1.15 
4 2 2 2 1 7 getrennt 30.00 6.49 0.19 -0.05 0.33 
4 2 2 2 1 8 getrennt 30.50 6.57 0.14 0.03 0.83 
4 2 2 2 1 9 getrennt 33.90 6.58 0.16 0.04 4.23 
4 2 3 2 2 1 getrennt 28.10 6.25 0.11 -0.29 -1.57 
4 2 3 2 2 2 getrennt 31.70 5.62 1.78 -0.92 2.03 
4 2 3 2 2 3 getrennt 29.70 5.91 0.75 -0.62 0.03 
4 2 3 2 2 4 getrennt 27.65 6.17 0.14 -0.36 -2.02 
4 2 3 2 2 5 Ÿberschn. 29.48 6.18 0.08 -0.35 -0.19 
4 2 3 2 2 6 Ÿberschn. 29.45 6.05 0.61 -0.49 -0.22 
4 2 3 2 2 7 getrennt 29.30 6.25 0.16 -0.28 -0.37 
4 2 3 2 2 8 getrennt 31.00 6.14 0.19 -0.40 1.33 
4 2 3 2 2 9 getrennt 32.20 5.98 0.71 -0.55 2.53 
4 3 2 1 1 1 Ÿberschn. 27.62 5.84 0.15 -0.70 -2.04 
4 3 2 1 1 2 getrennt 30.10 5.92 0.10 -0.61 0.43 
4 3 2 1 1 3 Ÿberschn. 29.81 5.83 0.19 -0.71 0.15 
4 3 2 1 1 4 getrennt 27.90 5.83 0.13 -0.71 -1.77 
4 3 2 1 1 5 getrennt 26.35 5.89 0.18 -0.64 -3.32 
4 3 2 1 1 6 getrennt 29.90 5.88 0.15 -0.65 0.23 
4 3 2 1 1 7 getrennt 29.60 5.77 0.18 -0.76 -0.07 
4 3 2 1 1 8 getrennt 30.50 5.85 0.16 -0.69 0.83 
4 3 2 1 1 9 getrennt 35.45 5.79 0.11 -0.75 5.78 
4 3 3 1 2 1 getrennt 26.65 5.57 0.07 -0.97 -3.02 
4 3 3 1 2 2 getrennt 30.10 5.44 0.13 -1.10 0.43 
4 3 3 1 2 3 getrennt 30.10 5.48 0.14 -1.06 0.43 
4 3 3 1 2 4 getrennt 28.10 5.44 0.10 -1.10 -1.57 
4 3 3 1 2 5 getrennt 28.70 5.46 0.10 -1.08 -0.97 





Table A2 continued 













4 3 3 1 2 6 getrennt 28.60 5.44 0.10 -1.09 -1.07 
4 3 3 1 2 7 getrennt 28.10 5.46 0.18 -1.07 -1.57 
4 3 3 1 2 8 Ÿberschn. 30.59 5.42 0.11 -1.12 0.93 
4 3 3 1 2 9 Ÿberschn. 32.76 5.34 0.14 -1.19 3.09 
5 1 2 3 2 1 Ÿberschn. 27.81 6.46 0.15 0.72 -0.40 
5 1 2 3 2 2 getrennt 30.10 6.42 0.26 0.67 1.89 
5 1 2 3 2 3 getrennt 28.70 6.66 0.08 0.91 0.49 
5 1 2 3 2 4 Ÿberschn. 22.71 6.52 0.25 0.77 -5.50 
5 1 2 3 2 5 getrennt 29.30 6.50 0.15 0.76 1.09 
5 1 2 3 2 6 getrennt 29.60 6.54 0.21 0.79 1.39 
5 1 2 3 2 7 Ÿberschn. 27.30 6.42 0.22 0.67 -0.91 
5 1 2 3 2 8 Ÿberschn. 30.39 6.47 0.14 0.72 2.18 
5 1 2 3 2 9 getrennt 30.55 6.56 0.27 0.81 2.34 
5 1 3 3 1 1 getrennt 29.30 6.38 0.98 0.63 1.09 
5 1 3 3 1 2 getrennt 29.20 6.39 0.33 0.64 0.99 
5 1 3 3 1 3 getrennt 29.10 6.39 0.32 0.64 0.89 
5 1 3 3 1 4 Ÿberschn. 26.86 6.44 0.27 0.69 -1.35 
5 1 3 3 1 5 getrennt 27.80 6.69 0.19 0.94 -0.41 
5 1 3 3 1 6 getrennt 29.10 6.83 0.12 1.08 0.89 
5 1 3 3 1 7 getrennt 27.90 6.48 0.36 0.73 -0.31 
5 1 3 3 1 8 getrennt 29.20 6.53 0.33 0.78 0.99 
5 1 3 3 1 9 Ÿberschn. 32.76 6.62 0.20 0.87 4.55 
5 2 2 1 2 1 getrennt 28.65 5.05 0.15 -0.70 0.44 
5 2 2 1 2 2 getrennt 28.00 4.82 0.20 -0.93 -0.21 
5 2 2 1 2 3 Ÿberschn. 28.26 4.74 0.21 -1.01 0.05 
5 2 2 1 2 4 Ÿberschn. 25.36 4.87 0.28 -0.87 -2.85 
5 2 2 1 2 5 getrennt 26.35 4.80 0.38 -0.95 -1.86 
5 2 2 1 2 6 Ÿberschn. 28.26 4.78 0.25 -0.97 0.05 
5 2 2 1 2 7 getrennt 26.50 4.95 0.27 -0.80 -1.71 
5 2 2 1 2 8 Ÿberschn. 28.63 4.99 0.37 -0.76 0.42 
5 2 2 1 2 9 Ÿberschn. 33.56 4.87 0.16 -0.87 5.35 
5 2 3 1 1 1 Ÿberschn. 28.25 4.47 0.20 -1.28 0.04 
5 2 3 1 1 2 getrennt 28.10 4.64 0.27 -1.11 -0.11 
5 2 3 1 1 3 getrennt 29.30 4.58 0.24 -1.17 1.09 
5 2 3 1 1 4 getrennt 23.25 4.49 0.38 -1.26 -4.96 
5 2 3 1 1 5 Ÿberschn. 24.70 4.56 0.28 -1.19 -3.51 
5 2 3 1 1 6 getrennt 27.55 4.64 0.25 -1.11 -0.66 
5 2 3 1 1 7 Ÿberschn. 26.49 4.54 0.24 -1.21 -1.72 
5 2 3 1 1 8 getrennt 28.10 4.73 0.22 -1.02 -0.11 
5 2 3 1 1 9 getrennt 31.00 4.55 0.17 -1.20 2.79 
5 3 2 2 2 1 getrennt 28.70 5.65 1.34 -0.10 0.49 
5 3 2 2 2 2 getrennt 29.30 5.91 0.47 0.16 1.09 
5 3 2 2 2 3 getrennt 29.30 5.36 1.50 -0.39 1.09 
5 3 2 2 2 4 getrennt 25.80 5.04 1.69 -0.71 -2.41 
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5 3 2 2 2 5 Ÿberschn. 27.81 5.69 1.09 -0.06 -0.40 
5 3 2 2 2 6 getrennt 28.60 6.31 0.23 0.56 0.39 
5 3 2 2 2 7 Ÿberschn. 26.69 5.58 1.25 -0.17 -1.52 
5 3 2 2 2 8 getrennt 29.30 6.05 0.58 0.30 1.09 
5 3 2 2 2 9 getrennt 31.00 6.27 0.11 0.52 2.79 
5 3 3 2 1 1 getrennt 28.00 6.20 0.31 0.45 -0.21 
5 3 3 2 1 2 getrennt 28.00 6.15 0.27 0.40 -0.21 
5 3 3 2 1 3 getrennt 27.85 6.17 0.48 0.42 -0.36 
5 3 3 2 1 4 Ÿberschn. 26.79 6.22 0.42 0.47 -1.42 
5 3 3 2 1 5 Ÿberschn. 25.05 6.38 0.09 0.63 -3.16 
5 3 3 2 1 6 getrennt 27.85 6.28 0.27 0.53 -0.36 
5 3 3 2 1 7 Ÿberschn. 25.62 6.29 0.36 0.55 -2.59 
5 3 3 2 1 8 getrennt 27.40 6.24 0.39 0.49 -0.81 
5 3 3 2 1 9 getrennt 32.20 6.30 0.29 0.55 3.99 
6 1 2 2 2 1 getrennt 29.30 4.67 0.18 0.05 -0.07 
6 1 2 2 2 2 getrennt 30.10 3.98 1.23 -0.64 0.73 
6 1 2 2 2 3 getrennt 30.10 4.61 0.17 -0.01 0.73 
6 1 2 2 2 4 getrennt 27.65 4.49 0.25 -0.13 -1.72 
6 1 2 2 2 5 getrennt 28.10 4.63 0.10 0.01 -1.27 
6 1 2 2 2 6 getrennt 30.00 4.66 0.20 0.04 0.63 
6 1 2 2 2 7 getrennt 28.10 4.45 0.79 -0.17 -1.27 
6 1 2 2 2 8 Ÿberschn. 29.58 4.55 0.13 -0.06 0.21 
6 1 2 2 2 9 getrennt 31.60 4.54 0.06 -0.08 2.23 
6 1 3 2 1 1 getrennt 30.60 4.36 0.19 -0.26 1.23 
6 1 3 2 1 2 getrennt 29.20 4.24 0.34 -0.38 -0.17 
6 1 3 2 1 3 getrennt 29.10 4.46 0.23 -0.16 -0.27 
6 1 3 2 1 4 Ÿberschn. 25.95 4.39 0.28 -0.22 -3.42 
6 1 3 2 1 5 Ÿberschn. 25.41 4.32 0.23 -0.29 -3.96 
6 1 3 2 1 6 Ÿberschn. 30.56 4.31 0.33 -0.31 1.19 
6 1 3 2 1 7 Ÿberschn. 28.59 4.44 0.22 -0.17 -0.78 
6 1 3 2 1 8 getrennt 28.85 4.26 0.31 -0.36 -0.52 
6 1 3 2 1 9 Ÿberschn. 33.62 4.54 0.22 -0.08 4.25 
6 2 2 1 2 1 getrennt 28.70 4.72 0.26 0.11 -0.67 
6 2 2 1 2 2 Ÿberschn. 29.82 4.63 0.13 0.01 0.45 
6 2 2 1 2 3 getrennt 30.10 4.51 0.17 -0.10 0.73 
6 2 2 1 2 4 getrennt 26.65 4.60 0.12 -0.02 -2.72 
6 2 2 1 2 5 Ÿberschn. 28.86 4.62 0.13 0.00 -0.51 
6 2 2 1 2 6 getrennt 30.50 4.61 0.21 0.00 1.13 
6 2 2 1 2 7 Ÿberschn. 28.47 4.68 0.20 0.06 -0.90 
6 2 2 1 2 8 getrennt 30.55 4.47 0.10 -0.15 1.18 
6 2 2 1 2 9 getrennt 31.60 4.61 0.13 0.00 2.23 
6 2 3 1 1 1 getrennt 29.70 4.50 0.21 -0.12 0.33 
6 2 3 1 1 2 getrennt 30.10 4.24 0.37 -0.38 0.73 
6 2 3 1 1 3 getrennt 29.50 4.50 0.33 -0.11 0.13 
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6 2 3 1 1 4 Ÿberschn. 26.48 4.35 0.27 -0.26 -2.89 
6 2 3 1 1 5 getrennt 27.30 4.29 0.34 -0.32 -2.07 
6 2 3 1 1 6 getrennt 29.50 4.42 0.24 -0.20 0.13 
6 2 3 1 1 7 getrennt 28.55 4.45 0.21 -0.17 -0.82 
6 2 3 1 1 8 getrennt 28.85 4.35 0.24 -0.27 -0.52 
6 2 3 1 1 9 getrennt 33.90 4.35 0.26 -0.27 4.53 
6 3 2 3 2 1 getrennt 29.70 5.07 0.15 0.45 0.33 
6 3 2 3 2 2 Ÿberschn. 30.82 5.10 0.15 0.48 1.45 
6 3 2 3 2 3 getrennt 29.70 5.03 0.29 0.41 0.33 
6 3 2 3 2 4 getrennt 27.65 4.96 0.18 0.34 -1.72 
6 3 2 3 2 5 getrennt 28.10 5.08 0.10 0.47 -1.27 
6 3 2 3 2 6 getrennt 30.00 5.02 0.22 0.41 0.63 
6 3 2 3 2 7 getrennt 28.10 5.04 0.24 0.42 -1.27 
6 3 2 3 2 8 getrennt 30.10 5.01 0.27 0.39 0.73 
6 3 2 3 2 9 getrennt 32.20 4.98 0.22 0.37 2.83 
6 3 3 3 1 1 getrennt 28.65 4.81 0.07 0.19 -0.72 
6 3 3 3 1 2 getrennt 29.65 5.03 0.24 0.41 0.28 
6 3 3 3 1 3 getrennt 30.40 4.73 0.21 0.11 1.03 
6 3 3 3 1 4 getrennt 27.40 4.67 0.28 0.05 -1.97 
6 3 3 3 1 5 getrennt 27.30 4.85 0.12 0.24 -2.07 
6 3 3 3 1 6 Ÿberschn. 28.37 4.84 0.23 0.23 -1.00 
6 3 3 3 1 7 getrennt 29.20 4.74 0.30 0.12 -0.17 
6 3 3 3 1 8 Ÿberschn. 29.20 4.63 0.20 0.01 -0.17 
6 3 3 3 1 9 getrennt 33.90 4.93 0.15 0.31 4.53 
7 1 2 1 2 1 getrennt 30.60 4.68 0.26 0.00 1.33 
7 1 2 1 2 2 getrennt 28.10 4.64 0.15 -0.05 -1.17 
7 1 2 1 2 3 getrennt 29.70 4.62 0.19 -0.06 0.43 
7 1 2 1 2 4 getrennt 29.30 4.66 0.14 -0.02 0.03 
7 1 2 1 2 5 getrennt 29.30 4.55 0.12 -0.14 0.03 
7 1 2 1 2 6 getrennt 30.00 4.70 0.19 0.01 0.73 
7 1 2 1 2 7 getrennt 28.70 4.66 0.11 -0.03 -0.57 
7 1 2 1 2 8 Ÿberschn. 29.70 4.65 0.22 -0.04 0.43 
7 1 2 1 2 9 getrennt 33.10 4.53 0.15 -0.16 3.83 
7 1 3 1 1 1 getrennt 29.70 4.15 0.15 -0.53 0.43 
7 1 3 1 1 2 getrennt 28.00 4.32 0.13 -0.37 -1.27 
7 1 3 1 1 3 getrennt 29.10 4.21 0.10 -0.47 -0.17 
7 1 3 1 1 4 getrennt 26.50 4.46 0.35 -0.22 -2.77 
7 1 3 1 1 5 getrennt 28.10 4.22 0.12 -0.47 -1.17 
7 1 3 1 1 6 getrennt 30.40 4.17 0.31 -0.52 1.13 
7 1 3 1 1 7 getrennt 28.55 4.18 0.18 -0.51 -0.72 
7 1 3 1 1 8 Ÿberschn. 28.63 4.16 0.15 -0.53 -0.64 
7 1 3 1 1 9 nurJa . 4.26 0.14 -0.43 . 
7 2 2 2 2 1 getrennt 30.60 5.40 0.26 0.71 1.33 
7 2 2 2 2 2 getrennt 28.70 5.16 0.59 0.47 -0.57 
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7 2 2 2 2 3 getrennt 30.10 5.32 0.37 0.63 0.83 
7 2 2 2 2 4 getrennt 27.65 4.94 0.51 0.25 -1.62 
7 2 2 2 2 5 getrennt 28.10 4.70 0.42 0.01 -1.17 
7 2 2 2 2 6 Ÿberschn. 30.69 5.02 0.58 0.34 1.42 
7 2 2 2 2 7 getrennt 28.10 4.87 0.36 0.18 -1.17 
7 2 2 2 2 8 Ÿberschn. 29.18 4.98 0.47 0.29 -0.08 
7 2 2 2 2 9 getrennt 33.10 5.19 0.55 0.51 3.83 
7 2 3 2 1 1 Ÿberschn. 28.45 4.37 0.49 -0.31 -0.81 
7 2 3 2 1 2 Ÿberschn. 27.91 4.55 0.42 -0.14 -1.36 
7 2 3 2 1 3 getrennt 28.75 4.39 0.32 -0.30 -0.52 
7 2 3 2 1 4 Ÿberschn. 29.18 4.40 0.35 -0.28 -0.08 
7 2 3 2 1 5 getrennt 25.90 4.28 0.30 -0.41 -3.37 
7 2 3 2 1 6 getrennt 29.10 4.43 0.45 -0.25 -0.17 
7 2 3 2 1 7 getrennt 27.40 4.42 0.39 -0.26 -1.87 
7 2 3 2 1 8 getrennt 29.20 4.55 0.29 -0.14 -0.07 
7 2 3 2 1 9 getrennt 32.20 4.20 0.18 -0.48 2.93 
7 3 2 3 2 1 getrennt 30.10 5.27 0.34 0.59 0.83 
7 3 2 3 2 2 getrennt 30.10 5.24 0.26 0.55 0.83 
7 3 2 3 2 3 getrennt 28.70 5.52 0.18 0.84 -0.57 
7 3 2 3 2 4 Ÿberschn. 29.66 5.28 0.21 0.60 0.39 
7 3 2 3 2 5 getrennt 30.10 5.24 0.24 0.55 0.83 
7 3 2 3 2 6 getrennt 30.00 5.27 0.16 0.59 0.73 
7 3 2 3 2 7 getrennt 28.70 5.38 0.10 0.69 -0.57 
7 3 2 3 2 8 Ÿberschn. 30.68 5.16 0.38 0.47 1.41 
7 3 2 3 2 9 getrennt 33.10 5.38 0.15 0.70 3.83 
7 3 3 3 1 1 getrennt 28.65 4.60 0.16 -0.08 -0.62 
7 3 3 3 1 2 getrennt 28.00 4.45 0.35 -0.24 -1.27 
7 3 3 3 1 3 getrennt 30.40 4.37 0.32 -0.31 1.13 
7 3 3 3 1 4 getrennt 27.90 4.85 0.15 0.16 -1.37 
7 3 3 3 1 5 Ÿberschn. 25.30 4.12 0.44 -0.57 -3.96 
7 3 3 3 1 6 getrennt 28.75 4.43 0.53 -0.25 -0.52 
7 3 3 3 1 7 Ÿberschn. 27.79 4.33 0.46 -0.36 -1.48 
7 3 3 3 1 8 Ÿberschn. 27.59 4.42 0.39 -0.27 -1.68 
7 3 3 3 1 9 getrennt 33.90 4.75 0.36 0.06 4.63 
8 1 2 1 2 1 getrennt 28.70 5.62 0.25 0.22 0.47 
8 1 2 1 2 2 Ÿberschn. 28.61 5.78 0.27 0.38 0.38 
8 1 2 1 2 3 getrennt 28.70 5.40 0.56 0.00 0.47 
8 1 2 1 2 4 getrennt 28.10 5.72 0.23 0.33 -0.13 
8 1 2 1 2 5 getrennt 28.70 5.96 0.11 0.57 0.47 
8 1 2 1 2 6 Ÿberschn. 28.70 5.85 0.21 0.45 0.47 
8 1 2 1 2 7 getrennt 28.70 5.66 0.27 0.27 0.47 
8 1 2 1 2 8 getrennt 29.30 4.84 2.15 -0.56 1.07 
8 1 2 1 2 9 Ÿberschn. 33.16 5.74 0.34 0.34 4.93 
8 1 3 1 1 1 Ÿberschn. 27.14 4.51 0.49 -0.88 -1.09 
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8 1 3 1 1 2 getrennt 28.00 5.06 0.50 -0.33 -0.23 
8 1 3 1 1 3 getrennt 28.40 4.91 0.54 -0.49 0.17 
8 1 3 1 1 4 getrennt 24.25 5.07 0.42 -0.33 -3.98 
8 1 3 1 1 5 Ÿberschn. 24.20 4.97 0.36 -0.43 -4.03 
8 1 3 1 1 6 Ÿberschn. 27.04 4.86 0.44 -0.54 -1.19 
8 1 3 1 1 7 Ÿberschn. 26.40 5.01 0.36 -0.39 -1.83 
8 1 3 1 1 8 getrennt 26.90 4.57 0.81 -0.83 -1.33 
8 1 3 1 1 9 getrennt 35.45 5.07 0.55 -0.33 7.22 
8 2 2 3 2 1 getrennt 28.00 5.56 0.50 0.16 -0.23 
8 2 2 3 2 2 Ÿberschn. 29.10 5.11 0.72 -0.29 0.87 
8 2 2 3 2 3 getrennt 28.40 5.53 0.40 0.13 0.17 
8 2 2 3 2 4 Ÿberschn. 24.94 5.47 0.39 0.08 -3.29 
8 2 2 3 2 5 getrennt 25.40 5.47 0.30 0.08 -2.83 
8 2 2 3 2 6 getrennt 28.40 5.39 0.64 -0.01 0.17 
8 2 2 3 2 7 getrennt 28.55 5.31 0.32 -0.09 0.32 
8 2 2 3 2 8 getrennt 27.90 5.34 0.55 -0.06 -0.33 
8 2 2 3 2 9 Ÿberschn. 35.63 5.55 0.41 0.15 7.40 
8 2 3 3 1 1 getrennt 25.30 4.46 0.68 -0.94 -2.93 
8 2 3 3 1 2 Ÿberschn. 27.33 4.46 0.75 -0.93 -0.90 
8 2 3 3 1 3 Ÿberschn. 27.55 4.90 0.77 -0.49 -0.68 
8 2 3 3 1 4 getrennt 24.35 4.84 0.57 -0.56 -3.88 
8 2 3 3 1 5 Ÿberschn. 25.85 4.92 0.57 -0.48 -2.38 
8 2 3 3 1 6 getrennt 26.90 4.60 0.55 -0.79 -1.33 
8 2 3 3 1 7 getrennt 25.20 5.01 0.26 -0.39 -3.03 
8 2 3 3 1 8 Ÿberschn. 27.73 4.66 0.56 -0.74 -0.50 
8 2 3 3 1 9 getrennt 31.60 4.92 0.51 -0.48 3.37 
8 3 2 2 2 1 getrennt 28.70 5.86 0.52 0.47 0.47 
8 3 2 2 2 2 getrennt 29.70 6.13 0.18 0.73 1.47 
8 3 2 2 2 3 getrennt 28.70 6.18 0.19 0.78 0.47 
8 3 2 2 2 4 getrennt 27.65 6.07 0.26 0.67 -0.58 
8 3 2 2 2 5 getrennt 28.70 6.21 0.29 0.82 0.47 
8 3 2 2 2 6 getrennt 28.00 6.00 0.35 0.60 -0.23 
8 3 2 2 2 7 getrennt 28.10 6.12 0.27 0.73 -0.13 
8 3 2 2 2 8 getrennt 29.70 6.06 0.30 0.66 1.47 
8 3 2 2 2 9 getrennt 33.10 6.11 0.19 0.72 4.87 
8 3 3 2 1 1 getrennt 28.65 5.48 0.46 0.08 0.42 
8 3 3 2 1 2 getrennt 27.50 5.59 0.32 0.19 -0.73 
8 3 3 2 1 3 getrennt 28.40 5.73 0.35 0.33 0.17 
8 3 3 2 1 4 getrennt 25.25 5.70 0.24 0.30 -2.98 
8 3 3 2 1 5 Ÿberschn. 24.79 5.63 0.28 0.23 -3.44 
8 3 3 2 1 6 Ÿberschn. 27.62 5.65 0.44 0.26 -0.61 
8 3 3 2 1 7 getrennt 27.90 5.62 0.40 0.23 -0.33 
8 3 3 2 1 8 getrennt 27.90 5.50 0.24 0.10 -0.33 
8 3 3 2 1 9 getrennt 35.45 5.67 0.41 0.28 7.22 
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9 1 2 1 1 1 getrennt 28.00 4.82 0.37 -0.81 0.14 
9 1 2 1 1 2 Ÿberschn. 28.27 4.83 0.21 -0.80 0.41 
9 1 2 1 1 3 Ÿberschn. 29.60 5.02 0.26 -0.61 1.74 
9 1 2 1 1 4 getrennt 26.10 5.04 0.29 -0.59 -1.76 
9 1 2 1 1 5 Ÿberschn. 25.21 4.80 0.29 -0.83 -2.65 
9 1 2 1 1 6 getrennt 27.30 4.82 0.46 -0.81 -0.56 
9 1 2 1 1 7 getrennt 27.90 4.92 0.35 -0.71 0.04 
9 1 2 1 1 8 getrennt 28.85 4.65 0.38 -0.98 0.99 
9 1 2 1 1 9 getrennt 30.90 4.78 0.33 -0.85 3.04 
9 1 3 1 2 1 getrennt 28.10 4.75 0.14 -0.88 0.24 
9 1 3 1 2 2 getrennt 28.70 4.68 0.27 -0.95 0.84 
9 1 3 1 2 3 getrennt 28.70 4.69 0.25 -0.94 0.84 
9 1 3 1 2 4 Ÿberschn. 22.93 4.88 0.27 -0.75 -4.93 
9 1 3 1 2 5 getrennt 26.10 4.78 0.30 -0.85 -1.76 
9 1 3 1 2 6 getrennt 24.30 4.79 0.26 -0.84 -3.56 
9 1 3 1 2 7 getrennt 28.10 4.80 0.18 -0.84 0.24 
9 1 3 1 2 8 Ÿberschn. 27.10 4.71 0.21 -0.92 -0.76 
9 1 3 1 2 9 getrennt 31.00 4.77 0.26 -0.86 3.14 
9 2 2 3 1 1 getrennt 28.65 6.68 0.37 1.04 0.79 
9 2 2 3 1 2 getrennt 28.00 6.72 0.23 1.09 0.14 
9 2 2 3 1 3 getrennt 28.75 6.74 0.27 1.11 0.89 
9 2 2 3 1 4 getrennt 26.90 6.47 0.36 0.84 -0.96 
9 2 2 3 1 5 Ÿberschn. 27.23 6.59 0.43 0.96 -0.63 
9 2 2 3 1 6 Ÿberschn. 27.59 6.57 0.30 0.93 -0.27 
9 2 2 3 1 7 Ÿberschn. 30.05 6.62 0.40 0.99 2.19 
9 2 2 3 1 8 Ÿberschn. 28.77 6.69 0.17 1.05 0.91 
9 2 2 3 1 9 getrennt 32.20 6.56 0.36 0.93 4.34 
9 2 3 3 2 1 getrennt 28.10 6.45 0.24 0.82 0.24 
9 2 3 3 2 2 getrennt 28.70 6.65 0.24 1.01 0.84 
9 2 3 3 2 3 Ÿberschn. 28.79 6.69 0.32 1.06 0.93 
9 2 3 3 2 4 getrennt 26.10 6.73 0.18 1.10 -1.76 
9 2 3 3 2 5 getrennt 24.60 6.60 0.28 0.97 -3.26 
9 2 3 3 2 6 Ÿberschn. 25.94 6.71 0.18 1.07 -1.92 
9 2 3 3 2 7 getrennt 28.10 6.58 0.20 0.95 0.24 
9 2 3 3 2 8 getrennt 28.70 6.71 0.23 1.08 0.84 
9 2 3 3 2 9 Ÿberschn. 29.70 6.65 0.34 1.02 1.84 
9 3 2 2 1 1 getrennt 26.60 5.47 0.06 -0.16 -1.26 
9 3 2 2 1 2 getrennt 28.60 5.72 0.17 0.09 0.74 
9 3 2 2 1 3 getrennt 28.75 5.37 0.19 -0.26 0.89 
9 3 2 2 1 4 Ÿberschn. 26.63 5.53 0.38 -0.10 -1.23 
9 3 2 2 1 5 Ÿberschn. 26.47 5.70 0.26 0.06 -1.39 
9 3 2 2 1 6 Ÿberschn. 27.62 5.45 0.43 -0.18 -0.24 
9 3 2 2 1 7 Ÿberschn. 28.67 5.46 0.39 -0.18 0.81 
9 3 2 2 1 8 getrennt 27.90 5.55 0.15 -0.08 0.04 
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9 3 2 2 1 9 Ÿberschn. 33.23 5.53 0.29 -0.10 5.37 
9 3 3 2 2 1 getrennt 28.10 5.65 0.22 0.02 0.24 
9 3 3 2 2 2 getrennt 28.70 5.26 0.31 -0.38 0.84 
9 3 3 2 2 3 Ÿberschn. 26.68 5.42 0.29 -0.21 -1.18 
9 3 3 2 2 4 getrennt 24.00 5.47 0.19 -0.16 -3.86 
9 3 3 2 2 5 Ÿberschn. 26.60 5.32 0.19 -0.31 -1.26 
9 3 3 2 2 6 Ÿberschn. 27.89 5.16 0.29 -0.47 0.03 
9 3 3 2 2 7 getrennt 26.55 5.37 0.24 -0.26 -1.31 
9 3 3 2 2 8 getrennt 28.10 5.49 0.20 -0.15 0.24 
9 3 3 2 2 9 getrennt 29.30 5.26 0.26 -0.38 1.44 
10 1 2 2 1 1 getrennt 28.65 4.19 0.16 0.31 -1.00 
10 1 2 2 1 2 getrennt 28.60 4.20 0.13 0.32 -1.05 
10 1 2 2 1 3 getrennt 28.75 4.26 0.09 0.39 -0.90 
10 1 2 2 1 4 getrennt 27.90 4.20 0.16 0.33 -1.75 
10 1 2 2 1 5 getrennt 28.75 4.03 0.20 0.15 -0.90 
10 1 2 2 1 6 getrennt 30.40 4.12 0.20 0.25 0.75 
10 1 2 2 1 7 getrennt 28.55 4.17 0.08 0.30 -1.10 
10 1 2 2 1 8 getrennt 30.00 4.18 0.17 0.31 0.35 
10 1 2 2 1 9 Ÿberschn. 34.39 4.19 0.24 0.32 4.74 
10 1 3 2 2 1 getrennt 28.10 3.87 0.24 -0.01 -1.55 
10 1 3 2 2 2 Ÿberschn. 29.32 4.08 0.28 0.21 -0.33 
10 1 3 2 2 3 getrennt 30.10 4.07 0.30 0.19 0.45 
10 1 3 2 2 4 getrennt 28.70 4.07 0.35 0.20 -0.95 
10 1 3 2 2 5 Ÿberschn. 29.83 4.06 0.17 0.19 0.18 
10 1 3 2 2 6 getrennt 29.60 4.17 0.21 0.30 -0.05 
10 1 3 2 2 7 getrennt 28.70 3.80 0.12 -0.08 -0.95 
10 1 3 2 2 8 getrennt 28.70 4.14 0.30 0.27 -0.95 
10 1 3 2 2 9 Ÿberschn. 30.65 3.97 0.18 0.09 1.00 
10 2 2 1 1 1 getrennt 28.00 3.21 0.17 -0.66 -1.65 
10 2 2 1 1 2 Ÿberschn. 30.69 3.23 0.14 -0.65 1.04 
10 2 2 1 1 3 getrennt 29.90 3.26 0.10 -0.61 0.25 
10 2 2 1 1 4 getrennt 30.00 3.13 0.15 -0.74 0.35 
10 2 2 1 1 5 Ÿberschn. 31.18 3.17 0.11 -0.70 1.53 
10 2 2 1 1 6 getrennt 29.90 3.20 0.13 -0.67 0.25 
10 2 2 1 1 7 Ÿberschn. 28.81 3.20 0.14 -0.67 -0.85 
10 2 2 1 1 8 getrennt 28.55 3.20 0.11 -0.67 -1.10 
10 2 2 1 1 9 Ÿberschn. 34.63 3.22 0.14 -0.65 4.98 
10 2 3 1 2 1 getrennt 28.10 2.91 0.09 -0.96 -1.55 
10 2 3 1 2 2 getrennt 29.30 2.97 0.12 -0.90 -0.35 
10 2 3 1 2 3 getrennt 29.30 2.98 0.10 -0.89 -0.35 
10 2 3 1 2 4 getrennt 28.10 2.94 0.11 -0.94 -1.55 
10 2 3 1 2 5 getrennt 30.10 3.02 0.11 -0.86 0.45 
10 2 3 1 2 6 getrennt 30.00 3.01 0.06 -0.86 0.35 
10 2 3 1 2 7 getrennt 27.60 2.90 0.06 -0.98 -2.05 
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10 2 3 1 2 8 getrennt 28.70 2.97 0.15 -0.90 -0.95 
10 2 3 1 2 9 getrennt 31.00 2.99 0.11 -0.89 1.35 
10 3 2 3 1 1 Ÿberschn. 29.59 4.27 0.18 0.40 -0.06 
10 3 2 3 1 2 Ÿberschn. 30.65 4.20 0.16 0.32 1.00 
10 3 2 3 1 3 getrennt 29.90 4.41 0.14 0.54 0.25 
10 3 2 3 1 4 Ÿberschn. 28.92 4.28 0.12 0.41 -0.73 
10 3 2 3 1 5 getrennt 28.10 4.38 0.08 0.51 -1.55 
10 3 2 3 1 6 Ÿberschn. 31.52 4.24 0.14 0.37 1.87 
10 3 2 3 1 7 getrennt 28.55 4.37 0.11 0.50 -1.10 
10 3 2 3 1 8 Ÿberschn. 30.50 4.25 0.18 0.37 0.85 
10 3 2 3 1 9 getrennt 33.90 4.33 0.10 0.46 4.25 
10 3 3 3 2 1 getrennt 28.10 4.59 0.09 0.72 -1.55 
10 3 3 3 2 2 getrennt 29.70 4.60 0.14 0.72 0.05 
10 3 3 3 2 3 getrennt 29.70 4.59 0.18 0.72 0.05 
10 3 3 3 2 4 getrennt 28.10 4.45 0.24 0.57 -1.55 
10 3 3 3 2 5 getrennt 30.55 4.60 0.08 0.73 0.90 
10 3 3 3 2 6 getrennt 29.60 4.54 0.08 0.67 -0.05 
10 3 3 3 2 7 getrennt 28.10 4.64 0.10 0.77 -1.55 
10 3 3 3 2 8 Ÿberschn. 30.55 4.64 0.11 0.76 0.90 
10 3 3 3 2 9 getrennt 31.60 4.50 0.07 0.63 1.95 
11 1 2 2 1 1 getrennt 27.50 6.66 0.10 0.09 -2.35 
11 1 2 2 1 2 getrennt 28.90 6.68 0.09 0.11 -0.95 
11 1 2 2 1 3 getrennt 29.10 6.76 0.11 0.20 -0.75 
11 1 2 2 1 4 Ÿberschn. 29.20 6.69 0.08 0.12 -0.65 
11 1 2 2 1 5 Ÿberschn. 27.77 6.66 0.11 0.09 -2.08 
11 1 2 2 1 6 Ÿberschn. 29.17 6.75 0.13 0.19 -0.68 
11 1 2 2 1 7 Ÿberschn. 27.34 6.72 0.13 0.15 -2.51 
11 1 2 2 1 8 getrennt 30.00 6.67 0.07 0.10 0.15 
11 1 2 2 1 9 getrennt 37.00 6.78 0.07 0.21 7.15 
11 1 3 2 2 1 getrennt 28.70 6.73 0.12 0.16 -1.15 
11 1 3 2 2 2 Ÿberschn. 29.49 6.78 0.13 0.21 -0.36 
11 1 3 2 2 3 getrennt 28.10 6.77 0.13 0.20 -1.75 
11 1 3 2 2 4 getrennt 28.70 6.76 0.16 0.19 -1.15 
11 1 3 2 2 5 getrennt 28.70 6.75 0.10 0.18 -1.15 
11 1 3 2 2 6 getrennt 28.60 6.71 0.17 0.15 -1.25 
11 1 3 2 2 7 getrennt 28.70 6.68 0.04 0.11 -1.15 
11 1 3 2 2 8 getrennt 30.10 6.73 0.15 0.17 0.25 
11 1 3 2 2 9 getrennt 32.20 6.73 0.12 0.16 2.35 
11 2 2 3 1 1 Ÿberschn. 31.22 6.39 0.20 -0.18 1.37 
11 2 2 3 1 2 Ÿberschn. 34.07 6.31 0.25 -0.26 4.22 
11 2 2 3 1 3 Ÿberschn. 30.31 6.23 0.23 -0.33 0.46 
11 2 2 3 1 4 getrennt 28.65 6.23 0.17 -0.34 -1.20 
11 2 2 3 1 5 getrennt 27.90 6.23 0.29 -0.34 -1.95 
11 2 2 3 1 6 getrennt 28.55 6.15 0.18 -0.42 -1.30 
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11 2 2 3 1 7 getrennt 28.10 6.21 0.18 -0.36 -1.75 
11 2 2 3 1 8 getrennt 30.90 6.15 0.20 -0.42 1.05 
11 2 2 3 1 9 getrennt 33.90 6.22 0.24 -0.35 4.05 
11 2 3 3 2 1 getrennt 28.10 6.74 0.18 0.18 -1.75 
11 2 3 3 2 2 Ÿberschn. 29.88 6.85 0.10 0.28 0.03 
11 2 3 3 2 3 Ÿberschn. 30.76 6.77 0.21 0.21 0.91 
11 2 3 3 2 4 getrennt 29.70 6.69 0.23 0.12 -0.15 
11 2 3 3 2 5 getrennt 28.70 6.66 0.18 0.09 -1.15 
11 2 3 3 2 6 getrennt 30.55 6.80 0.18 0.23 0.70 
11 2 3 3 2 7 getrennt 31.00 6.68 0.13 0.11 1.15 
11 2 3 3 2 8 getrennt 29.20 6.81 0.12 0.25 -0.65 
11 2 3 3 2 9 Ÿberschn. 33.18 6.77 0.22 0.20 3.33 
11 3 2 1 1 1 getrennt 28.00 6.66 0.14 0.09 -1.85 
11 3 2 1 1 2 getrennt 29.20 6.73 0.12 0.16 -0.65 
11 3 2 1 1 3 Ÿberschn. 28.37 6.56 0.11 0.00 -1.48 
11 3 2 1 1 4 getrennt 30.00 6.66 0.15 0.09 0.15 
11 3 2 1 1 5 Ÿberschn. 27.45 6.73 0.07 0.16 -2.40 
11 3 2 1 1 6 getrennt 29.50 6.73 0.12 0.16 -0.35 
11 3 2 1 1 7 Ÿberschn. 27.35 6.59 0.13 0.03 -2.51 
11 3 2 1 1 8 getrennt 28.55 6.71 0.09 0.14 -1.30 
11 3 2 1 1 9 Ÿberschn. 36.45 6.65 0.11 0.08 6.60 
11 3 3 1 2 1 getrennt 28.10 6.15 0.27 -0.42 -1.75 
11 3 3 1 2 2 Ÿberschn. 31.09 6.25 0.39 -0.32 1.24 
11 3 3 1 2 3 getrennt 30.10 6.39 0.13 -0.18 0.25 
11 3 3 1 2 4 Ÿberschn. 29.82 6.21 0.34 -0.36 -0.03 
11 3 3 1 2 5 getrennt 30.10 6.45 0.07 -0.11 0.25 
11 3 3 1 2 6 getrennt 29.60 6.28 0.20 -0.28 -0.25 
11 3 3 1 2 7 getrennt 28.10 6.22 0.40 -0.34 -1.75 
11 3 3 1 2 8 getrennt 30.55 6.45 0.18 -0.12 0.70 
11 3 3 1 2 9 Ÿberschn. 35.67 6.30 0.25 -0.27 5.82 
12 1 2 2 2 1 getrennt 26.65 7.91 0.08 0.13 -3.31 
12 1 2 2 2 2 getrennt 31.70 7.91 0.06 0.13 1.74 
12 1 2 2 2 3 getrennt 30.10 7.90 0.13 0.11 0.14 
12 1 2 2 2 4 getrennt 28.70 7.87 0.10 0.09 -1.26 
12 1 2 2 2 5 Ÿberschn. 29.66 7.87 0.10 0.08 -0.30 
12 1 2 2 2 6 getrennt 30.00 7.89 0.12 0.11 0.04 
12 1 2 2 2 7 getrennt 28.70 7.87 0.13 0.08 -1.26 
12 1 2 2 2 8 Ÿberschn. 30.34 7.93 0.11 0.15 0.38 
12 1 2 2 2 9 getrennt 32.20 7.95 0.10 0.17 2.24 
12 1 3 2 1 1 getrennt 28.00 7.88 0.14 0.10 -1.96 
12 1 3 2 1 2 getrennt 29.20 7.83 0.23 0.04 -0.76 
12 1 3 2 1 3 getrennt 29.10 7.87 0.19 0.09 -0.86 
12 1 3 2 1 4 Ÿberschn. 28.35 7.84 0.15 0.05 -1.60 
12 1 3 2 1 5 getrennt 27.80 7.89 0.13 0.11 -2.16 
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12 1 3 2 1 6 Ÿberschn. 28.11 7.84 0.22 0.05 -1.85 
12 1 3 2 1 7 getrennt 31.00 7.90 0.12 0.11 1.04 
12 1 3 2 1 8 getrennt 30.00 7.81 0.24 0.02 0.04 
12 1 3 2 1 9 getrennt 35.45 7.97 0.18 0.19 5.49 
12 2 2 1 2 1 getrennt 30.10 7.81 0.13 0.03 0.14 
12 2 2 1 2 2 getrennt 30.60 7.81 0.18 0.03 0.64 
12 2 2 1 2 3 getrennt 30.10 7.82 0.09 0.03 0.14 
12 2 2 1 2 4 getrennt 28.10 7.69 0.22 -0.09 -1.86 
12 2 2 1 2 5 getrennt 28.70 7.78 0.16 0.00 -1.26 
12 2 2 1 2 6 getrennt 30.00 7.77 0.15 -0.01 0.04 
12 2 2 1 2 7 getrennt 30.55 7.79 0.16 0.00 0.59 
12 2 2 1 2 8 getrennt 30.10 7.73 0.23 -0.06 0.14 
12 2 2 1 2 9 Ÿberschn. 35.85 7.82 0.14 0.04 5.90 
12 2 3 1 1 1 getrennt 29.70 7.63 0.07 -0.16 -0.26 
12 2 3 1 1 2 Ÿberschn. 30.31 7.51 0.17 -0.28 0.35 
12 2 3 1 1 3 Ÿberschn. 29.34 7.42 0.14 -0.37 -0.62 
12 2 3 1 1 4 Ÿberschn. 27.02 7.53 0.21 -0.26 -2.94 
12 2 3 1 1 5 Ÿberschn. 27.45 7.40 0.25 -0.38 -2.50 
12 2 3 1 1 6 getrennt 29.90 7.57 0.18 -0.21 -0.06 
12 2 3 1 1 7 getrennt 30.00 7.46 0.19 -0.33 0.04 
12 2 3 1 1 8 getrennt 29.60 7.60 0.17 -0.19 -0.36 
12 2 3 1 1 9 getrennt 35.45 7.58 0.07 -0.21 5.49 
12 3 2 3 2 1 getrennt 27.65 7.68 0.21 -0.10 -2.31 
12 3 2 3 2 2 getrennt 30.10 7.81 0.13 0.03 0.14 
12 3 2 3 2 3 getrennt 30.10 7.83 0.10 0.04 0.14 
12 3 2 3 2 4 getrennt 28.10 7.79 0.07 0.00 -1.86 
12 3 2 3 2 5 Ÿberschn. 28.88 7.72 0.17 -0.06 -1.08 
12 3 2 3 2 6 Ÿberschn. 31.39 7.70 0.22 -0.08 1.43 
12 3 2 3 2 7 Ÿberschn. 29.48 7.83 0.10 0.04 -0.48 
12 3 2 3 2 8 getrennt 31.60 7.83 0.12 0.04 1.64 
12 3 2 3 2 9 Ÿberschn. 35.26 7.71 0.17 -0.08 5.31 
12 3 3 3 1 1 getrennt 28.65 7.85 0.25 0.06 -1.31 
12 3 3 3 1 2 getrennt 28.00 7.97 0.15 0.18 -1.96 
12 3 3 3 1 3 getrennt 29.90 7.84 0.14 0.06 -0.06 
12 3 3 3 1 4 Ÿberschn. 27.94 7.80 0.21 0.01 -2.02 
12 3 3 3 1 5 getrennt 27.30 7.88 0.32 0.09 -2.66 
12 3 3 3 1 6 getrennt 29.90 7.94 0.16 0.16 -0.06 
12 3 3 3 1 7 getrennt 28.55 7.75 0.21 -0.03 -1.41 
12 3 3 3 1 8 getrennt 29.60 7.95 0.20 0.17 -0.36 
12 3 3 3 1 9 Ÿberschn. 37.40 7.86 0.21 0.07 7.44 
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